[Hormonal treatment of juvenile menstruation disorders].
D000293:Adolescent; D004958:Estradiol / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008234:Lynestrenol / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000188:drug therapy*; D008656:Mestranol / Q000627:therapeutic use; D009641:Norethynodrel / Q000627:therapeutic use; D009654:Norsteroids / Q000627:therapeutic use; D011284:Pregnenolone / Q000627:therapeutic use; D011374:Progesterone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use*
D004967:Estrogens; D009654:Norsteroids; D011372:Progestins; D011374:Progesterone; D004958:Estradiol; D011284:Pregnenolone; D009641:Norethynodrel; D008656:Mestranol; D008234:Lynestrenol
Hormonelle Behandlung der juvenilen Blutungsstörungen.